Pictet Asset Management Holding SA »

Miragen Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $19M 1.1M 17.51

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Miragen Therapeutics

FMR
Paradigm Biocapital Advisors
State Street Corporation
VR Adviser
BlackRock
Perceptive Advisors
Deep Track Capital
Vanguard Group
Maverick Capital
Commodore Capital
Fairmount Funds Management
Alliancebernstein
Vivo Capital
Dr. Jeffrey R. Jay, M.D.
Nuveen Asset Management

View all funds holding Miragen Therapeutics